Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
Pfizer(PFE) stock is priced at $25.79, giving the company a market capitalization of 146.61B. It carries a P/E multiple of 15.17 and pays a dividend yield of 6.6%.
As of 2025-12-08, Pfizer(PFE) stock has fluctuated between $25.75 and $26.19. The current price stands at $25.79, placing the stock +0.2% above today's low and -1.5% off the high.
Pfizer(PFE) shares are trading with a volume of 45.21M, against a daily average of 43.95M.
In the last year, Pfizer(PFE) shares hit a 52-week high of $27.69 and a 52-week low of $20.92.
In the last year, Pfizer(PFE) shares hit a 52-week high of $27.69 and a 52-week low of $20.92.
PFE News
Mixed options sentiment in Pfizer (PFE), with shares up 4c, or 0.13%, near $26.07. Options volume roughly in line with average with 117k contracts traded and ca...
Pfizer (PFE) just put fresh data behind one of its more interesting pipeline assets, with Phase 3 results showing HYMPAVZI improved bleeding outcomes for hemoph...
Eli Lilly (LLY), Pfizer (PFE), and Johnson & Johnson (JNJ) have secured spots on China’s drug catalog, with a total of 19 medicines making the list, Amber Tong...
Analyst ratings
57%
of 28 ratingsMore PFE News
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Pfizer (NYSE: PF...
Key Points Pfizer has a sizable 6.8% yield and is down nearly 60% from its 2021 highs. Bristol Myers Squibb has a 5% yield and is off its 2023 highs by nearly...
Pfizer and Astellas previously announced that the FDA approved PADCEV (enfortumab vedotin-ejfv) plus Keytruda as a perioperative treatment for cisplatin-ineligi...
Investors in Pfizer Inc (Symbol: PFE) saw new options become available today, for the June 2027 expiration. One of the key data points that goes into the price...